Contineum Therapeutics (CTNM) Property, Plant & Equipment (Net) (2023 - 2026)

Contineum Therapeutics (CTNM) Property, Plant & Equipment (Net) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Oculis Holding AG 65,719.23 Bn 65,718.94 Bn - 642,333.36
2 Nanobiotix 1,933.82 Bn 1,933.76 Bn - 5.32 Mn
3 Akari Therapeutics 959.56 Bn 959.56 Bn - -
4 BeOne Medicines 470.97 Bn 466.18 Bn 1.35 Bn 1.64 Bn
5 Vertex Pharmaceuticals 122.29 Bn 115.05 Bn 2.59 Bn 1.61 Bn
6 Regeneron Pharmaceuticals 69.98 Bn 61.22 Bn 3.31 Bn 5.27 Bn
7 Belite Bio 62.06 Bn 62.06 Bn - -
8 Argenx Se 55.78 Bn 50.60 Bn 1.41 Bn 1.96 Bn
9 Alnylam Pharmaceuticals 37.43 Bn 34.42 Bn 959.66 Mn 518.26 Mn
10 Contineum Therapeutics 524.99 Mn 524.99 Mn - 1.06 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.06 Mn
Mar 31, 2026 1.06 Mn
Dec 31, 2025 830,000.00
Dec 31, 2025 830,000.00
Sep 30, 2025 880,000.00
Sep 30, 2025 880,000.00
Jun 30, 2025 856,000.00
Jun 30, 2025 856,000.00
Mar 31, 2025 891,000.00
Mar 31, 2025 891,000.00
Dec 31, 2024 989,000.00
Dec 31, 2024 989,000.00
Sep 30, 2024 888,000.00
Sep 30, 2024 888,000.00
Jun 30, 2024 801,000.00
Jun 30, 2024 801,000.00
Mar 31, 2024 756,000.00
Mar 31, 2024 756,000.00
Dec 31, 2023 678,000.00
Dec 31, 2023 678,000.00